Notably, SIRT4 plays a pivotal role in the suppression of tumorigenesis across a spectrum of cancer types (such as colorectal cancer, breast cancer, prostate cancer, etc.), consistent with its low expression levels in these tumors. Here, SIRT4 is linked to breast carcinoma.